REMI AI Discrete Detection Module
Overview
The REMI AI Discrete Detection Module, developed by Epitel, is an innovative artificial intelligence (AI) tool designed to enhance electroencephalogram (EEG) monitoring for seizure detection. It integrates seamlessly into the broader REMI Remote EEG Monitoring System, which utilizes wearable, wireless sensors to capture high-fidelity EEG data.
This module conducts automated analysis of EEG data in near real-time, providing notifications of potential electrographic seizures. It is intended to assist physicians qualified to analyze and interpret EEG by identifying and annotating potential seizure events, including their confidence level and duration.
The REMI system, including its AI modules, aims to make EEG monitoring more accessible, affordable, and reliable, moving beyond traditional, cumbersome wired systems. It supports long-duration monitoring in various settings, from hospital emergency rooms and critical care units to ambulatory (at-home) environments.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- Automated EEG data analysis for seizure detection
- Near real-time notifications of potential electrographic seizures
- Integration with REMI Remote EEG Monitoring System
- Wearable, wireless EEG sensors for patient comfort and mobility
- Cloud-based data analytics and machine learning capabilities
- Simplified application process, not requiring an EEG technician
- Provides high-fidelity EEG recordings
- Reimbursable using preexisting CPT codes
- Supports monitoring for adult and pediatric patients (6+ years for AI module, 1+ years for REMI System)
- Annotations of detected events with confidence level and duration
Use Cases
- Rapid seizure detection in neurological emergencies (e.g., post-convulsive seizure, non-convulsive status epilepticus)
- EEG monitoring in hospital emergency rooms and critical care units
- Extended-duration ambulatory (at-home) EEG monitoring
- Tracking the frequency and duration of seizures over time
- Assisting physicians in the interpretation and analysis of EEG records
- Facilitating rapid identification of seizures at the point-of-care, especially in facilities without 24/7 EEG coverage
What Physicians Need to Know
The REMI AI Discrete Detection Module is intended as an assistive tool for qualified physicians in reviewing and interpreting EEG data, not as a standalone diagnostic solution or a substitute for professional judgment. While the Rapid Detection Module offers near real-time alerts, clinicians should be aware that delays can occur. The system does not provide diagnostic conclusions or treatment recommendations. Its design aims to enhance access to EEG monitoring, particularly in healthcare settings that may lack continuous EEG coverage or specialized technicians. The AI's confidence levels for detected events can aid in the interpretation process.
The REMI AI Discrete Detection Module seamlessly integrates with the Epitel REMI Remote EEG Monitoring System, analyzing EEG data collected and stored by the system. The REMI Mobile software transmits data from REMI Sensors to a secure REMI Cloud, where it is processed and prepared for review using qualified EEG viewing software, specifically mentioning compatibility with Persystu2122 Mobile. The REMI tablet, part of the system, requires a secure WiFi connection for data transmission.
Details
| Category | Neurology AI, Wearables & Remote Monitoring (RPM) |
| Pricing | Unknown |
| Deployment | Cloud-based platform with a mobile application (REMI Mobile) running on qualified commercial off-the-shelf mobile computing platforms (Android tablets/smartwatches). |
| Compliance | |
| BAA Available | Unknown AI-estimated |
| HIPAA Compliant | Unknown AI-estimated |
| FDA Status |
1 AI-estimated The REMI AI Discrete Detection Module received FDA 510(k) clearance (K231779) on January 2, 2024. It is a seizure detection module that conducts automated analysis of EEG data collected by the REMI System in near real-time, providing notifications of potential electrographic seizures. It is indicated for use with adult and pediatric patients (6+ years) and is intended for use by physicians qualified to analyze and interpret EEG. |
| Integrations | |
| EHR | Not specified |
| Specialties | Neurology, Pediatrics |
What the Web Says
The Epitel REMI AI Discrete Detection Module (also referred to as REMI Vigilenz AI for Event Detection) is an FDA-cleared software as a medical device (SaMD) designed to assist physicians in reviewing electroencephalogram (EEG) recordings by automatically identifying and annotating potential electrographic seizures. It is intended for use with Epitel's REMI Remote EEG Monitoring System, which utilizes wearable sensors for extended, ambulatory EEG monitoring in both healthcare facilities and home environments. The AI categorizes seizure-like events with confidence levels to improve the ease and speed of interpretation for qualified physicians.
Overall: PositiveStrengths
- Aids physicians in identifying potential electrographic seizures in EEG recordings.
- Improves ease and speed of interpretation by categorizing seizure-like events with confidence levels.
- Leverages state-of-the-art machine learning for event detection.
- Allows for extended EEG monitoring in outpatient and home environments, increasing the chance of capturing infrequent seizures.
- Reduces the burden and restrictiveness of traditional wired EEG systems for patients.
- Cleared by the FDA with a Predetermined Change Control Plan (PCCP), allowing for ongoing performance improvements.
Limitations
- Does not mark REMI EEG records in real-time.
- Does not provide any diagnostic conclusion about the patient's condition; it is an aid to physician review.
- Some neurologists have expressed skepticism about machine learning in EEG interpretation, requiring further familiarization and trust in the technology.
- Initial studies showed a slight increase in false alarm rates with machine learning, although sensitivity improved.
- Only analyzes previously acquired EEG data from 4-channel recordings.
- Not validated for and not indicated for detection of electrographic status epilepticus.
Based on reviews from: accessdata.fda.gov, BioUtah, BioWorld, Practical Patient Care, BioSpace, YouTube (Epilepsy Foundation Pipeline Conference), PMC (PubMed Central), Aletia Index, Epitel (epitel.com), MedTech Innovator, Reimagine Care, Medical Device Network, OR Today
Last updated: 2026-07-17
Ratings & Reviews
Rate REMI AI Discrete Detection Module
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for REMI AI Discrete Detection Module.
Frequently Asked Questions
Investors who backed REMI AI Discrete Detection Module
Funded through the company that built this tool.
